EndoBarrier Gastrointestinal Liner: Pivotal trial final data

Final data from 320 inadequately controlled obese patients with Type II diabetes in the modified intent-to-treat (mITT) population of the double-blind, U.S. pivotal ENDO trial showed

Read the full 263 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE